[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-001", "question": "A 45-year-old male presents with syncope. ECG shows sinus rhythm with first-degree AV block and a right bundle branch block. Echocardiogram reveals a left ventricular ejection fraction (LVEF) of 42% with mild LV dilation. Genetic testing confirms a pathogenic variant in the LMNA gene (Lamin A/C). He has no history of sustained ventricular tachycardia. Which of the following is the most appropriate management?", "options": ["Implantation of a dual-chamber pacemaker", "Implantation of an implantable cardioverter-defibrillator (ICD)", "Implantation of an implantable loop recorder", "Initiation of Amiodarone", "Initiation of Metoprolol and reassessment of LVEF in 3 months"], "answer": "B", "answer_index": 1, "explanation": "Lamin A/C (LMNA) cardiomyopathy carries a disproportionately high risk of malignant ventricular arrhythmias and sudden cardiac death, often independent of the degree of LV dysfunction. Current guidelines recommend ICD implantation for patients with an LMNA mutation and risk factors such as AV block, male sex, or non-missense mutations, even if the LVEF is >35%. A pacemaker alone addresses the conduction disease but leaves the patient unprotected against the high risk of fatal ventricular arrhythmias.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe item is medically accurate and logically sound. LMNA cardiomyopathy is distinct from general dilated cardiomyopathy due to a disproportionately high risk of sudden cardiac death (SCD) from malignant ventricular arrhythmias and high-grade AV block. Current guidelines (e.g., 2022 ESC Guidelines for Ventricular Arrhythmias) recommend ICD implantation for patients with LMNA mutations who have an LVEF < 50% and additional risk factors (such as male sex and conduction defects). This patient has an LVEF of 42%, male sex, conduction disease (RBBB + 1st-degree AVB), and syncope, making ICD implantation (Option B) the clear best answer for primary prevention of SCD and management of potential bradyarrhythmias. A pacemaker alone (Option A) is insufficient because it does not protect against VT/VF. A loop recorder (Option C) is inappropriate given the high risk and established indication for treatment. Waiting for medical optimization (Option E) is the standard for general heart failure but is superseded by the specific high-risk genetic profile of LMNA, where ICDs are indicated earlier.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe item is medically accurate and logically sound. LMNA cardiomyopathy is distinct from general dilated cardiomyopathy due to a disproportionately high risk of sudden cardiac death (SCD) from malignant ventricular arrhythmias and high-grade AV block. Current guidelines (e.g., 2022 ESC Guidelines for Ventricular Arrhythmias) recommend ICD implantation for patients with LMNA mutations who have an LVEF < 50% and additional risk factors (such as male sex and conduction defects). This patient has an LVEF of 42%, male sex, conduction disease (RBBB + 1st-degree AVB), and syncope, making ICD implantation (Option B) the clear best answer for primary prevention of SCD and management of potential bradyarrhythmias. A pacemaker alone (Option A) is insufficient because it does not protect against VT/VF. A loop recorder (Option C) is inappropriate given the high risk and established indication for treatment. Waiting for medical optimization (Option E) is the standard for general heart failure but is superseded by the specific high-risk genetic profile of LMNA, where ICDs are indicated earlier.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-002", "question": "A 68-year-old male presents with a 3-week history of brief, involuntary jerking movements of his right face and arm, occurring up to 40 times per day. He remains conscious during these events. Interictal EEG and brain MRI are unremarkable. He is beginning to show signs of short-term memory impairment. Which of the following is the most appropriate initial treatment?", "options": ["Levetiracetam", "Carbamazepine", "Intravenous Methylprednisolone", "Tissue Plasminogen Activator (tPA)", "Haloperidol"], "answer": "C", "answer_index": 2, "explanation": "The clinical presentation is classic for faciobrachial dystonic seizures (FBDS), which are pathognomonic for Anti-LGI1 encephalitis (a form of limbic encephalitis). These seizures are characteristically resistant to standard anti-epileptic drugs but respond dramatically to immunotherapy (steroids, IVIG). Early recognition and treatment with immunotherapy are crucial to prevent the progression to severe cognitive impairment and full-blown limbic encephalitis.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe vignette describes faciobrachial dystonic seizures (FBDS)—frequent, brief, involuntary jerking of the face and arm with preserved awareness—accompanied by subacute memory impairment. This presentation is pathognomonic for anti-LGI1 encephalitis. A critical teaching point for this condition is that FBDS are characteristically resistant to standard anti-epileptic drugs (Options A and B) but respond robustly to immunotherapy. Therefore, Intravenous Methylprednisolone (Option C) is the correct best answer to arrest seizure activity and prevent permanent cognitive sequelae. Option D is contraindicated given the 3-week duration. Option E is inappropriate. The item is medically accurate and logically sound, testing a specific, high-yield association in neuroimmunology.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe vignette describes faciobrachial dystonic seizures (FBDS)—frequent, brief, involuntary jerking of the face and arm with preserved awareness—accompanied by subacute memory impairment. This presentation is pathognomonic for anti-LGI1 encephalitis. A critical teaching point for this condition is that FBDS are characteristically resistant to standard anti-epileptic drugs (Options A and B) but respond robustly to immunotherapy. Therefore, Intravenous Methylprednisolone (Option C) is the correct best answer to arrest seizure activity and prevent permanent cognitive sequelae. Option D is contraindicated given the 3-week duration. Option E is inappropriate. The item is medically accurate and logically sound, testing a specific, high-yield association in neuroimmunology.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-003", "question": "A 55-year-old female is admitted to the ICU with sepsis and severe malnutrition. She has a history of chronic back pain managed with acetaminophen. Arterial blood gas shows pH 7.26, pCO2 28 mmHg, HCO3 12 mEq/L. Serum chemistry shows Na 140, Cl 104, BUN 18, Cr 0.8. Lactate is 1.1 mmol/L. Serum ketones are negative. Measured serum osmolality is 295 mOsm/kg (calculated 290). Which of the following is the most likely etiology of her metabolic acidosis?", "options": ["Methanol intoxication", "D-lactic acidosis", "Pyroglutamic acidosis (5-oxoproline accumulation)", "Propylene glycol toxicity", "Salicylate toxicity"], "answer": "C", "answer_index": 2, "explanation": "The patient has a high anion gap metabolic acidosis (AG = 24) with a normal lactate, no ketones, normal renal function, and a normal osmol gap (ruling out toxic alcohols like methanol or propylene glycol). The combination of chronic acetaminophen use, sepsis, and malnutrition leads to glutathione depletion, causing a disruption in the gamma-glutamyl cycle and accumulation of 5-oxoproline (pyroglutamic acid). This is an under-recognized cause of high anion gap acidosis in this specific patient population.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The patient presents with a high anion gap metabolic acidosis (AG = 140 - (104 + 12) = 24) with a normal osmolar gap (295 - 290 = 5), normal L-lactate, and negative ketones. The vignette provides the classic triad of risk factors for pyroglutamic acidosis (5-oxoproline accumulation): chronic acetaminophen use, severe malnutrition, and sepsis (often in women). These factors deplete glutathione, disrupting the gamma-glutamyl cycle and causing 5-oxoproline buildup. Methanol (A) and propylene glycol (D) are ruled out by the normal osmolar gap. D-lactic acidosis (B) is typically associated with short bowel syndrome, which is not mentioned. Salicylate toxicity (E) is less likely given the explicit history of acetaminophen use and lack of specific salicylate signs (e.g., tinnitus). The question is logically sound, medically accurate, and clearly points to a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The patient presents with a high anion gap metabolic acidosis (AG = 140 - (104 + 12) = 24) with a normal osmolar gap (295 - 290 = 5), normal L-lactate, and negative ketones. The vignette provides the classic triad of risk factors for pyroglutamic acidosis (5-oxoproline accumulation): chronic acetaminophen use, severe malnutrition, and sepsis (often in women). These factors deplete glutathione, disrupting the gamma-glutamyl cycle and causing 5-oxoproline buildup. Methanol (A) and propylene glycol (D) are ruled out by the normal osmolar gap. D-lactic acidosis (B) is typically associated with short bowel syndrome, which is not mentioned. Salicylate toxicity (E) is less likely given the explicit history of acetaminophen use and lack of specific salicylate signs (e.g., tinnitus). The question is logically sound, medically accurate, and clearly points to a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-004", "question": "A 34-year-old male presents with progressive dyspnea. He has a BMI of 17 kg/m2. Chest radiography shows apical pleural thickening. High-resolution CT demonstrates upper-lobe predominant subpleural fibrosis and a flattened chest configuration ('platythorax'). He has no history of asbestos exposure or connective tissue disease. Which of the following is the most likely diagnosis?", "options": ["Idiopathic Pulmonary Fibrosis (IPF)", "Pleuroparenchymal Fibroelastosis (PPFE)", "Chronic Hypersensitivity Pneumonitis", "Lymphangioleiomyomatosis (LAM)", "Pulmonary Alveolar Proteinosis"], "answer": "B", "answer_index": 1, "explanation": "Pleuroparenchymal Fibroelastosis (PPFE) is a rare idiopathic interstitial pneumonia characterized by fibrosis of the visceral pleura and subpleural lung parenchyma, predominantly in the upper lobes. The radiographic hallmark is the 'platythorax' (flattening of the chest cage) due to fibrosis progression. This contrasts with IPF (lower lobe predominant) and Hypersensitivity Pneumonitis (mosaic attenuation, centrilobular nodules).", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict on keyed answer: Correct best. The vignette provides a textbook description of Pleuroparenchymal Fibroelastosis (PPFE). Key discriminating features include the patient's young age (34), low BMI (17 kg/m2 is characteristic of PPFE), upper-lobe predominant subpleural fibrosis, and the specific finding of 'platythorax' (flattening of the chest cage). These findings make PPFE the only plausible diagnosis among the options. Option A (IPF) is typically lower-lobe predominant and occurs in older adults. Option C (Chronic HP) may affect upper lobes but is characterized by mosaic attenuation and air trapping, not platythorax. Option D (LAM) is a cystic lung disease almost exclusively seen in females. Option E (PAP) presents with 'crazy-paving' and is not fibrotic. The item is medically accurate and logically sound, pointing uniquely to the keyed answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The vignette provides a textbook description of Pleuroparenchymal Fibroelastosis (PPFE). Key discriminating features include the patient's young age (34), low BMI (17 kg/m2 is characteristic of PPFE), upper-lobe predominant subpleural fibrosis, and the specific finding of 'platythorax' (flattening of the chest cage). These findings make PPFE the only plausible diagnosis among the options. Option A (IPF) is typically lower-lobe predominant and occurs in older adults. Option C (Chronic HP) may affect upper lobes but is characterized by mosaic attenuation and air trapping, not platythorax. Option D (LAM) is a cystic lung disease almost exclusively seen in females. Option E (PAP) presents with 'crazy-paving' and is not fibrotic. The item is medically accurate and logically sound, pointing uniquely to the keyed answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-005", "question": "A 24-year-old African American male presents with cyanosis and shortness of breath after taking dapsone for a skin lesion. Pulse oximetry reads 85% and does not improve with supplemental oxygen. Arterial blood gas shows a normal PaO2 but methemoglobin level is 18%. He has a known history of hemolysis after ingesting fava beans. Which of the following is the most appropriate treatment?", "options": ["Methylene Blue 1 mg/kg IV", "Ascorbic Acid (Vitamin C) IV", "Hydroxocobalamin IV", "Hyperbaric Oxygen Therapy", "Sodium Thiosulfate IV"], "answer": "B", "answer_index": 1, "explanation": "The patient has methemoglobinemia precipitated by dapsone. However, his history of hemolysis with fava beans strongly suggests Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. Methylene blue is contraindicated in G6PD deficiency because it requires NADPH (generated by G6PD) to reduce methemoglobin; without G6PD, methylene blue is ineffective and can induce severe hemolysis. Ascorbic acid (Vitamin C) or exchange transfusion is the appropriate management.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette presents a classic case of acquired methemoglobinemia (dapsone-induced) in a patient with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency (indicated by fava bean hemolysis). While Methylene Blue is the standard first-line antidote, it is strictly contraindicated in G6PD deficiency because it requires NADPH to function and can precipitate severe hemolysis. Ascorbic Acid (Vitamin C) is the standard board-exam alternative pharmacologic therapy for this specific contraindication, despite its slow clinical efficacy. While Hyperbaric Oxygen is a potential rescue therapy for severe cases, Vitamin C is the specific pharmacologic discriminator intended for this scenario. The item correctly tests the contraindication and the alternative agent. The logic is sound, and the distractors are appropriate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette presents a classic case of acquired methemoglobinemia (dapsone-induced) in a patient with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency (indicated by fava bean hemolysis). While Methylene Blue is the standard first-line antidote, it is strictly contraindicated in G6PD deficiency because it requires NADPH to function and can precipitate severe hemolysis. Ascorbic Acid (Vitamin C) is the standard board-exam alternative pharmacologic therapy for this specific contraindication, despite its slow clinical efficacy. While Hyperbaric Oxygen is a potential rescue therapy for severe cases, Vitamin C is the specific pharmacologic discriminator intended for this scenario. The item correctly tests the contraindication and the alternative agent. The logic is sound, and the distractors are appropriate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-006", "question": "A 14-year-old boy with a history of exercise-induced syncope is diagnosed with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) confirmed by an RyR2 mutation. He is compliant with high-dose Nadolol. A repeat exercise stress test shows a reduction in arrhythmia burden, but he still develops runs of bidirectional ventricular tachycardia at peak exertion. Which of the following is the best next step in management?", "options": ["Switch Nadolol to Metoprolol Succinate", "Add Flecainide", "Perform Radiofrequency Ablation of the ventricular focus", "Implant a dual-chamber pacemaker", "Add Verapamil"], "answer": "B", "answer_index": 1, "explanation": "In patients with CPVT who have breakthrough arrhythmias despite optimal beta-blocker therapy (preferably Nadolol or Propranolol), the addition of Flecainide is the guideline-recommended next step. Flecainide has a direct blocking effect on the cardiac ryanodine receptor (RyR2), addressing the underlying mechanism. Radiofrequency ablation is generally ineffective due to the polymorphic/multifocal nature of the arrhythmia.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette presents a classic scenario of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) refractory to first-line therapy. The patient is on the optimal beta-blocker (Nadolol) but continues to have high-risk breakthrough arrhythmia (bidirectional VT) on exertion. According to major guidelines (HRS/EHRA/APHRS), the standard next step in management for CPVT patients with breakthrough arrhythmias on beta-blockers is the addition of Flecainide. Flecainide has a specific mechanism of action in CPVT by inhibiting the cardiac ryanodine receptor (RyR2). Switching to Metoprolol (Option A) is incorrect as non-selective beta-blockers like Nadolol are preferred. Radiofrequency ablation (Option C) is generally ineffective for CPVT due to the diffuse nature of the arrhythmia. Pacemakers (Option D) do not treat the arrhythmia, and while ICDs are considered for cardiac arrest survivors or refractory cases, medication optimization is the priority here. Verapamil (Option E) is less effective than Flecainide. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette presents a classic scenario of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) refractory to first-line therapy. The patient is on the optimal beta-blocker (Nadolol) but continues to have high-risk breakthrough arrhythmia (bidirectional VT) on exertion. According to major guidelines (HRS/EHRA/APHRS), the standard next step in management for CPVT patients with breakthrough arrhythmias on beta-blockers is the addition of Flecainide. Flecainide has a specific mechanism of action in CPVT by inhibiting the cardiac ryanodine receptor (RyR2). Switching to Metoprolol (Option A) is incorrect as non-selective beta-blockers like Nadolol are preferred. Radiofrequency ablation (Option C) is generally ineffective for CPVT due to the diffuse nature of the arrhythmia. Pacemakers (Option D) do not treat the arrhythmia, and while ICDs are considered for cardiac arrest survivors or refractory cases, medication optimization is the priority here. Verapamil (Option E) is less effective than Flecainide. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-007", "question": "A 26-year-old female with a history of sensorineural hearing loss and short stature presents with acute onset aphasia and right-sided hemiparesis. MRI shows a T2-hyperintense lesion in the left temporal lobe that does not conform to a vascular territory. Serum lactate is elevated. Which of the following agents is indicated for the acute management of this condition?", "options": ["Intravenous Tissue Plasminogen Activator (tPA)", "Intravenous Arginine", "Intravenous Heparin", "High-dose Aspirin", "Plasma Exchange"], "answer": "B", "answer_index": 1, "explanation": "The clinical picture (stroke-like episode not respecting vascular territories, hearing loss, elevated lactate) is classic for MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes). The stroke-like episodes are due to metabolic failure and microvascular angiopathy (nitric oxide deficiency), not thrombotic occlusion. Intravenous Arginine is the recommended acute treatment to improve nitric oxide availability and cerebral blood flow. tPA is not indicated and could be harmful.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The vignette presents a classic textbook description of MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes). Key diagnostic clues include the combination of short stature, sensorineural hearing loss, elevated lactate, and a stroke-like lesion that does not respect vascular territories. The question asks for acute management of this specific condition. Intravenous L-arginine is the standard guideline-recommended therapy for the acute phase of MELAS stroke-like episodes, hypothesized to improve nitric oxide availability and cerebral blood flow. Standard ischemic stroke protocols (tPA) are generally avoided or not indicated because the pathophysiology is metabolic/microvascular rather than thromboembolic. Heparin, Aspirin, and Plasma Exchange do not address the underlying metabolic crisis. The item is medically accurate, logically sound, and supports a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The vignette presents a classic textbook description of MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes). Key diagnostic clues include the combination of short stature, sensorineural hearing loss, elevated lactate, and a stroke-like lesion that does not respect vascular territories. The question asks for acute management of this specific condition. Intravenous L-arginine is the standard guideline-recommended therapy for the acute phase of MELAS stroke-like episodes, hypothesized to improve nitric oxide availability and cerebral blood flow. Standard ischemic stroke protocols (tPA) are generally avoided or not indicated because the pathophysiology is metabolic/microvascular rather than thromboembolic. Heparin, Aspirin, and Plasma Exchange do not address the underlying metabolic crisis. The item is medically accurate, logically sound, and supports a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-008", "question": "A 32-year-old female is evaluated for palpitations. Labs reveal a TSH of 7.2 mIU/L (High) and Free T4 of 2.9 ng/dL (High). An MRI of the pituitary shows a 5mm hypoenhancing lesion. Sex Hormone Binding Globulin (SHBG) levels are elevated. Which of the following is the most likely diagnosis?", "options": ["Resistance to Thyroid Hormone (RTH) beta", "TSH-secreting pituitary adenoma (TSHoma)", "Graves' disease", "Familial Dysalbuminemic Hyperthyroxinemia", "Heterophile antibody interference"], "answer": "B", "answer_index": 1, "explanation": "Both RTH and TSHoma present with inappropriate TSH secretion (high T4, non-suppressed TSH). The key differentiator is the peripheral tissue response. In TSHoma, peripheral tissues (like the liver) are sensitive to the high thyroid hormone levels, resulting in elevated markers of thyroid action such as Sex Hormone Binding Globulin (SHBG). In RTH, the peripheral tissues are resistant, so SHBG levels are typically normal. The pituitary lesion supports TSHoma, but incidentalomas are common; the metabolic profile (high SHBG) confirms the diagnosis.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item correctly identifies a classic endocrine differential diagnosis: distinguishing TSH-secreting pituitary adenoma (TSHoma) from Resistance to Thyroid Hormone (RTH). Both conditions present with the syndrome of inappropriate TSH secretion (elevated Free T4 with non-suppressed TSH). The vignette provides two critical discriminating features: a pituitary lesion and elevated Sex Hormone Binding Globulin (SHBG). While pituitary incidentalomas are relatively common, making the lesion suggestive but not definitive, the elevated SHBG is the decisive pathophysiological clue. SHBG synthesis in the liver is upregulated by thyroid hormone. In TSHoma, peripheral tissues (including the liver) remain sensitive to the excess thyroid hormone, leading to elevated SHBG and clinical symptoms of thyrotoxicosis (palpitations). Conversely, RTH is characterized by a defect in the thyroid hormone receptor beta, leading to peripheral resistance; consequently, markers of thyroid action like SHBG are typically normal or low despite high circulating hormone levels. The combination of the anatomical evidence (pituitary mass) and the biochemical evidence of peripheral tissue sensitivity (high SHBG) makes TSHoma the unambiguous best answer. The question is medically accurate, aligns with standard board-exam teaching, and contains no logical flaws.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item correctly identifies a classic endocrine differential diagnosis: distinguishing TSH-secreting pituitary adenoma (TSHoma) from Resistance to Thyroid Hormone (RTH). Both conditions present with the syndrome of inappropriate TSH secretion (elevated Free T4 with non-suppressed TSH). The vignette provides two critical discriminating features: a pituitary lesion and elevated Sex Hormone Binding Globulin (SHBG). While pituitary incidentalomas are relatively common, making the lesion suggestive but not definitive, the elevated SHBG is the decisive pathophysiological clue. SHBG synthesis in the liver is upregulated by thyroid hormone. In TSHoma, peripheral tissues (including the liver) remain sensitive to the excess thyroid hormone, leading to elevated SHBG and clinical symptoms of thyrotoxicosis (palpitations). Conversely, RTH is characterized by a defect in the thyroid hormone receptor beta, leading to peripheral resistance; consequently, markers of thyroid action like SHBG are typically normal or low despite high circulating hormone levels. The combination of the anatomical evidence (pituitary mass) and the biochemical evidence of peripheral tissue sensitivity (high SHBG) makes TSHoma the unambiguous best answer. The question is medically accurate, aligns with standard board-exam teaching, and contains no logical flaws.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-009", "question": "A 48-year-old male who works as a tool grinder presents with chronic dry cough and dyspnea. Bronchoalveolar lavage (BAL) reveals multinucleated giant cells that appear to be engulfing other cells ('cannibalistic' giant cells). Which of the following exposures is most likely responsible for this finding?", "options": ["Silica", "Asbestos", "Cobalt", "Beryllium", "Coal dust"], "answer": "C", "answer_index": 2, "explanation": "The presence of 'cannibalistic' multinucleated giant cells in BAL or biopsy is pathognomonic for Hard Metal Lung Disease (Giant Cell Interstitial Pneumonia). This is caused by exposure to Cobalt, often in the form of tungsten carbide alloy used in tool grinding, diamond polishing, or saw sharpening. Beryllium causes granulomas similar to sarcoidosis, not GIP.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid)\\nVerdict: Correct best answer\\n\\nThe vignette presents a classic occupational medicine case: a tool grinder presenting with respiratory symptoms and the specific pathognomonic finding of 'cannibalistic' multinucleated giant cells in BAL. This histological pattern defines Giant Cell Interstitial Pneumonia (GIP), which is the hallmark of Hard Metal Lung Disease. The causative agent in hard metal alloys (typically tungsten carbide) is Cobalt (Option C). \\n\\nThe distractors are incorrect based on the specific pathology described:\\n- Silica (A) causes silicotic nodules.\\n- Asbestos (B) is associated with ferruginous bodies and pleural plaques.\\n- Beryllium (D) causes non-caseating granulomas indistinguishable from sarcoidosis.\\n- Coal dust (E) causes coal macules and nodules.\\n\\nThe item is logically sound, medically accurate, and relies on a well-established board-exam association. The key is uniquely correct.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid)\nVerdict: Correct best answer\n\nThe vignette presents a classic occupational medicine case: a tool grinder presenting with respiratory symptoms and the specific pathognomonic finding of 'cannibalistic' multinucleated giant cells in BAL. This histological pattern defines Giant Cell Interstitial Pneumonia (GIP), which is the hallmark of Hard Metal Lung Disease. The causative agent in hard metal alloys (typically tungsten carbide) is Cobalt (Option C). \n\nThe distractors are incorrect based on the specific pathology described:\n- Silica (A) causes silicotic nodules.\n- Asbestos (B) is associated with ferruginous bodies and pleural plaques.\n- Beryllium (D) causes non-caseating granulomas indistinguishable from sarcoidosis.\n- Coal dust (E) causes coal macules and nodules.\n\nThe item is logically sound, medically accurate, and relies on a well-established board-exam association. The key is uniquely correct.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-010", "question": "A 52-year-old male presents to the ED 2 hours after ingesting a massive overdose of sustained-release Verapamil. He is hypotensive (BP 60/40 mmHg) and bradycardic (HR 38 bpm). He remains hypotensive despite 3 liters of crystalloid, IV Calcium Gluconate, and IV Glucagon. Which of the following is the most appropriate next therapeutic intervention?", "options": ["High-dose Insulin Euglycemia therapy", "Transvenous Pacing", "Hemodialysis", "IV Amiodarone", "IV Lipid Emulsion (20%)"], "answer": "A", "answer_index": 0, "explanation": "High-dose Insulin Euglycemia (HIE) is the recommended therapy for severe calcium channel blocker toxicity refractory to initial measures (fluids, calcium). Insulin has a positive inotropic effect and improves myocardial glucose utilization in the stressed heart. While lipid emulsion is a salvage therapy, HIE has stronger evidence as a first-line pharmacologic support after calcium/fluids. Transvenous pacing often fails to capture or improve cardiac output in severe CCB poisoning due to global myocardial depression.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette describes severe verapamil (calcium channel blocker) toxicity presenting with cardiogenic shock (hypotension, bradycardia) that is refractory to standard first-line therapies (fluids, calcium, glucagon). High-dose Insulin Euglycemia (HIE) is the widely accepted, evidence-based second-line therapy for CCB toxicity with myocardial dysfunction. It improves cardiac contractility and overcomes metabolic blockade. Among the distractors: Transvenous pacing (B) addresses heart rate but not the underlying negative inotropy and often fails to improve cardiac output in severe CCB poisoning. Hemodialysis (C) is ineffective due to verapamil's high protein binding and volume of distribution. Amiodarone (D) is contraindicated as it would worsen bradycardia and hypotension. Lipid Emulsion (E) is a valid therapy but is typically reserved for peri-arrest settings or cases refractory to HIE and vasopressors (salvage therapy). Therefore, HIE is the distinct best answer among the choices provided. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette describes severe verapamil (calcium channel blocker) toxicity presenting with cardiogenic shock (hypotension, bradycardia) that is refractory to standard first-line therapies (fluids, calcium, glucagon). High-dose Insulin Euglycemia (HIE) is the widely accepted, evidence-based second-line therapy for CCB toxicity with myocardial dysfunction. It improves cardiac contractility and overcomes metabolic blockade. Among the distractors: Transvenous pacing (B) addresses heart rate but not the underlying negative inotropy and often fails to improve cardiac output in severe CCB poisoning. Hemodialysis (C) is ineffective due to verapamil's high protein binding and volume of distribution. Amiodarone (D) is contraindicated as it would worsen bradycardia and hypotension. Lipid Emulsion (E) is a valid therapy but is typically reserved for peri-arrest settings or cases refractory to HIE and vasopressors (salvage therapy). Therefore, HIE is the distinct best answer among the choices provided. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]